Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

This study has been completed.
Information provided by:
Sanofi Identifier:
First received: December 20, 2002
Last updated: April 20, 2012
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2005
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):